Clinical Study
Clinical Outcomes and Prognostic Factors of 695 Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiotherapy
Table 2
Dose-volume statistics for targets (average result).
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
GTVnx: gross target volume; GTVln-L/R: positive neck lymph nodes; CTV1: high-risk region of clinical tumor volume; CTV2: low- risk region of clinical tumor volume; CTVln: lymph node region of clinical tumor volume; : percentage of volume receiving 95% of prescribed dose. |